In cases in which medicine tries to use protein based drugs, the drug is always administered by an injection since these medications do not survive the body’s digestive tract. Yet Oramed, an innovative Israeli Israeli pharmaceutical company located in Jerusalem, has been working hard to change that. The company has come up with a technology which helps an oral capsule pass through the gastrointestinal tract unharmed, and releases its protein based medication in the small intestine where it is absorbed by the blood stream. Once this new capsule passes testing stages and has been approved by the FDA, millions of people will benefit from higher quality of life and less expensive medical treatment. That’s a sensational message for many people suffering from diabetes.
Published: December 7, 2015Add to favorites. To view your favorites click here